Mohammed Taimi

Mohammed Taimi is an accomplished professional in the field of clinical pharmacology and pharmacometrics, currently serving as Senior Director of Clinical Pharmacology and Pharmacometrics at Keros Therapeutics. Previously, Mohammed held the position of Senior Director of Non-clinical, Clinical and Quantitative Pharmacology at Alexion Pharmaceuticals, part of the AstraZeneca Rare Disease division. Additional experience includes roles as Senior Director of DMPK and Clinical Pharmacology at Constellation Pharmaceuticals and Director of DMPK and Clinical Pharmacology at Silicon Therapeutics. Mohammed began a career in research as a Senior Investigator at Novartis Institutes for BioMedical Research (NIBR).